期刊文献+

RECK基因在胰腺癌中的表达及其与预后的关系 被引量:2

Expression of RECK in pancreatic carcinoma and its relationship with prognosis
原文传递
导出
摘要 目的观察人胰腺癌组织及细胞株中RECK基因的表达,探讨重组慢病毒LV-RECK对胰腺癌动物模型的治疗效果以及该基因与胰腺癌预后的关系。方法免疫组化法检测42例胰腺癌及相应正常胰腺组织中RECK的表达,分析RECK表达与胰腺癌临床病理特征及预后的关系。采用Western Blotting法检测三个胰腺癌细胞株(PANC-1,MIAPa Ca-2,AsPC1)中RECK的表达。统计分析RECK基因表达与临床病理特征及预后的关系。建立胰腺癌动物模型,应用LV—RECK进行治疗,观察抑瘤效果,并进行生存分析。结果RECK在胰腺癌细胞株中不表达。胰腺癌组织的RECK表达率(45.2%)较正常胰腺组织(88.1%)明显降低(P〈0.01)。RECK表达与胰腺癌的TNM分期、淋巴结转移、局部浸润存在相关性(P〈0.05)。Kaplan-Meier生存分析显示,RECK阳性表达组患者的生存期较阴性组明显延长(P=0.000)。单因素Cox分析显示,RECK表达、TNM分期、淋巴结转移及局部浸润与预后有关(P〈0.05)。多因素Cox分析显示,只有RECK表达具有独立的预后意义(P=0.000)。动物实验中,LVRECK治疗组移植瘤明显缩小(P〈0.05),微血管密度明显降低(P〈0.05),凋亡指数显著升高(P〈O.05),生存期显著延长(P〈0.05)。结论RECK表达与胰腺癌的侵袭转移及预后密切相关,可作为胰腺癌的独立预后指标。RECK基因过表达可以抑制肿瘤血管新生,诱导肿瘤细胞凋亡,从而抑制移植瘤的生长,改善荷瘤鼠的预后,为胰腺癌治疗提供了一个新的途径。 Objective To study the expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) in human pancreatic carcinoma tissues and pancreatic carcinoma cell lines; the effects of recombinant lentiviruses carrying RECK gene(LV-RECK) therapy on human pancreatic car cinoma xenograft in nude mice; and to find out the relationship between the expression of RECK and the prognosis of pancreatic carcinoma. Methods Immunohistochemical method was used to detect the expression of RECK in the resected specimens of pancreatic carcinoma and their corresponding normal pancreatic tissues in 42 patients. Western blotting was used to examine the expression of RECK in human pancreatic carcinoma cell lines (PANC-1, MIAPaCa-2, AsPC-1). Statistical analyses were performed to determine the relationship between RECK expression and the clinicopathological characteristics and prognosis in pancreatic carcinoma. Subcutaneous xenograft tumor models of human pancreatic carcinoma were established in nude mice. These nude mice were then divided into the experimental group, the negative control group and the blank control group randomly. The three groups of nude mice were intratumorally injected with LV-RECK, LV-EGFP and normal saline (NS) respectively. The antitumor effect was studied. Immunohistocbemical method was used to detect the expression of RECK and microvessel density (MVD). Terminal deoxynucleotidyl transferase mediated dUTP-DIG nick end labeling (TUNEL) was used to detect the apoptosis of tumor cells. Survival analysis was performed. Results All three pancreatic carcinoma cell lines did not express RECK. The overall positive rate of RECK expression was 45.2% (19/42) in pancreatic carcinoma, and 88.1% (37/42) in normal pancreatic tissue. The expression level of RECK was significantly lower in the tumor tissues than inthe normal tissues (P〈0.01). The expression of RECK was significantly associated with TNM stage, lymph node metastasis and local infiltration of pancreatic carcinoma (P〈0.05). Kap]an Meier survival analysis revealed that the survival time was significantly longer in the RECK positive patient group than in the RECK negative patient group. Univariate Cox regression analysis revealed that RECK expression, TNM stage, lymph node metastasis and local infihration were significantly related with prognosis for pancreatic carcinoma (P〈0.05). Multivariate Cox regression analysis revealed that only RECK expression remained as an independent significant factor in predicting the prognosis of pan- creatic carcinoma (P〈0.001). When compared with the negative control and the blank control groups, the volume of subcutaneous xenograft tumor in the experimental group was significantly de creased (P〈0.05). RECK protein in the experimental group was re-expressed. MVD of the expert mental group was significantly less than those of the control groups (P〈0.05). Apoptoticindex (AI) of the experimental group was significantly higher than those of the control groups (P〈0.05). The survival time of nude mice in the experimental group was significantly longer than those in the control groups (P〈0.05). Conclusions RECK expression was closely related to invasion, metastasis and prognosis of pancreatic carcinoma and it was an independent prognostic marker. RECK gene over-ex pression inhibited neovascularization of pancreatic carcinoma, induced apoptosis of tumor cells, inhibi ted the growth of tumor xenograft and improved the prognosis of tumor bearing mice. These results suggest a possible new treatment for pancreatic carcinoma.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2013年第8期580-585,共6页 Chinese Journal of Hepatobiliary Surgery
关键词 胰腺肿瘤 基质金属蛋白酶 预后 RECK基因 Pancreatic neoplasms Matrix metalloproteinases Prognosis Reversion-inducing cysteine rich protein with Kazal motifs
  • 相关文献

参考文献13

  • 1李晟磊,赵秋民,刘宗文,赵志华,高冬玲,郑湘予,陈奎生,张云汉.食管鳞癌中RECK和MMP-9蛋白表达的相关性及临床病理意义[J].世界华人消化杂志,2007,15(10):1082-1086. 被引量:34
  • 2王凤力,李德春,张子祥,谢于.胰腺癌裸鼠皮下瘤模型建立的比较研究[J].苏州大学学报(医学版),2007,27(3):359-360. 被引量:6
  • 3Weidner N. Intratumor microvessel density as a prognostic fac tot in cancer[J]. Am J Pathol, 1995,147 : 9-19.
  • 4徐怀勇,巩本刚,高崇崇,李梦字,吴俊本,相亭海,成丕光.新型基质金属蛋白酶抑制剂MMI-166对裸鼠胰腺癌移植瘤作用的研究[J].中华肝胆外科杂志,2012,18(11):859-862. 被引量:6
  • 5Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK[J]. Proc Natl Acad Sci USA, 1998,95:13221-13226.
  • 6Noda M, Oh J, Takahashi R, et al. RECK: a novel suppres- sor of malignancy linking oncogenic signaling to extracellular matrix remodeling[J]. Cancer Metastasis Rev, 2003, 22: 167 175.
  • 7Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis[J]. Cell, 2001,107 : 789-800.
  • 8Namwat N, Puetkasichonpasutha J, Loilome W, et al. Down regulation of reversion inducing-cysteine rich protein with Ka zal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases [J]. J Gastroenterol, 2011,46:664-675.
  • 9Stenzinger A, von Winterfeld M, Rabien A, et al. Reversion- inducing cysteine rich protein with Kazal motif (RECK) ex- pression: an independent prognostic marker of survival in colo- rectal cancer[J]. Hum Pathol, 2012,43:1314 1321.
  • 10Deng YF, Zhou DN, Ye CS, et al. Aberrant expression levels of MTA1 and RECK in nasopharyngeal carcinoma: association with metastasis, recurrence, and prognosis [J] Ann Otol Rhinol Laryngol, 2012,121:457 465.

二级参考文献14

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2陈亚琳,魏品康,许玲,苏晓妹.采用OB胶粘贴法建立人胃癌裸鼠原位种植转移模型[J].癌症,2005,24(2):246-248. 被引量:32
  • 3李毅清,张勇,郑启昌.Expression of RECK Gene and MMP-9 in Hilar Cholangiocarcinoma and Its Clinical Significance[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2005,25(5):552-554. 被引量:2
  • 4徐振宇,高建平,张征宇,葛京平,许传亮,孙颖浩.基质金属蛋白酶抑制剂RECK基因在前列腺细胞株中的表达及意义[J].中华男科学杂志,2005,11(10):727-730. 被引量:9
  • 5Tamura Y, Watanabe H, Nakatani T, et al. Highly selectiveand orally active inhibitors of type 1V collagenase (MMP-9 and MMP-2) : nsulfonylamino acid derivatives[J]. Journal of Me- dicinal Chemistry, 1998, 41: 640-649.
  • 6Haruhiko F, Kazuya K, Hisashi I, et al. Matrix metallopro- teinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer [J]. Mol Cancer Ther, 2005, 4: 1409-1416.
  • 7Manabu O, Hiroyuki K, Tatsuo T, et al, Effect of combina- tion therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer[J]. Cancer Res, 2001, 92:688-695.
  • 8Matsushita A, Onda M, Uchida E, et al. Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer E[J]. Int J Cancer, 2001, 92 : 434-440.
  • 9Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Fit-1 in squamous cell lung cancerE[J]. Int J Cancer, 1997, 74:64-68.
  • 10Faral S, Sail MW. Supportive and palliative care of pancreatic cancer[J]. JOP, 2007, 8:240-253.

共引文献43

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部